Answers are grounded in this paper and cite their sources.
Isolupalbigenin and M-Wi-2 could lead to the development of compounds for new approaches against MRSA infection.
No takes yet. Share an insight, caveat, or question.
Satô et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: